Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Cipla
Queensland Health
Cerilliant
US Department of Justice
Daiichi Sankyo
Citi
Julphar

Generated: May 22, 2018

DrugPatentWatch Database Preview

ORNIDYL Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Ornidyl patents expire, and what generic alternatives are available?

Ornidyl is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in ORNIDYL is eflornithine hydrochloride. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the eflornithine hydrochloride profile page.
Summary for ORNIDYL
Drug patent expirations by year for ORNIDYL
Medical Subject Heading (MeSH) Categories for ORNIDYL
Synonyms for ORNIDYL
.alpha.-DFMO HCl
2-(Difluoromethyl)-DL-ornithine HCl
2-(Difluoromethyl)-DL-ornithine hydrochloride
2-(Difluoromethyl)-DL-ornithine monohydrochloride
2,5-bis(azanyl)-2-[bis(fluoranyl)methyl]pentanoic acid hydrochloride
2,5-diamino-2-(difluoromethyl)pentanoic acid hydrochloride
278E239
68278-23-9
70050-56-5
A836071
A836749
AB0012930
ABP001097
AC-388
AC1L1M41
AK117776
AKOS015895186
AM033563
AN-15865
AN-37832
AOB5501
API0002527
BC207801
C-11969
C6H13ClF2N2O2
CAS-96020-91-6
CCG-221733
CCRIS 5805
CHEMBL536971
CS-2984
CTK8F9319
D,L-alpha-Difluoromethylornithine hydrochloride
dfmo
DFMO HCl
DFMO HCl;Eflornithine HCl
DFMO hydrochloride
DL- -Difluoromethylornithine hydrochloride
DL-2-(Difluoromethyl)-ornithine hydrochloride
DL-alpha-Difluoromethylornithine HCl
DL-alpha-Difluoromethylornithine hydrochloride
DL-alpha-Difluoromethylornithine hydrochloride hydrate
DL-Ornithine, 2-(difluoromethyl)-, monohydrochloride
DL-Ornithine, monohydrochloride
DMFO Hydrochloride
DSSTox_CID_25765
DSSTox_GSID_45765
DSSTox_RID_81107
DTXSID4045765
E0947
Eflornithine HCl H;DFMO HCl H;-Difluoromethylornithine HCl H
Eflornithine (hydrochloride)
Eflornithine HCl
EFLORNITHINE HYDROCHLORIDE
Eflornithine hydrochloride anhydrous
Eflornithine Hydrocloride
Eflornithinehydrochloride
EINECS 269-532-0
EU-0100429
FT-0082608
FT-0630774
H--Difluoro-Me-DL-Orn-OH HCl H
HY-B0744A
I06-0316
KM1188
KS-00002WVD
KS-1261
LP00429
LS-98405
MLS000069341
MLS001332583
MolPort-003-940-991
NCGC00015316-05
NCGC00093850-01
NCGC00261114-01
NSC 270295
NSC 337250
NSC-270295
NSC270295
Opera_ID_46
Ornithine, 2-(difluoromethyl)-, monohydrochloride
SBB066102
SCHEMBL3022583
SMR000058442
SR-01000076229
SR-01000076229-1
Tox21_111224
Tox21_111224_1
Tox21_500429
Vaniqa
Vaniqa hydrochloride

US Patents and Regulatory Information for ORNIDYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us ORNIDYL eflornithine hydrochloride INJECTABLE;INJECTION 019879-002 Nov 28, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for ORNIDYL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us ORNIDYL eflornithine hydrochloride INJECTABLE;INJECTION 019879-002 Nov 28, 1990 ➤ Sign Up ➤ Sign Up
Sanofi Aventis Us ORNIDYL eflornithine hydrochloride INJECTABLE;INJECTION 019879-002 Nov 28, 1990 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Argus Health
Chubb
AstraZeneca
Mallinckrodt
UBS
Moodys
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.